2009
Hormonal Contraception and Metabolic Outcomes in Women With or at Risk for HIV Infection
Womack JA, Scherzer R, Cole SR, Fennie K, Williams AB, Grey M, Minkoff H, Anastos K, Cohen MH, Tien PC. Hormonal Contraception and Metabolic Outcomes in Women With or at Risk for HIV Infection. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2009, 52: 581-587. PMID: 19950431, PMCID: PMC2886798, DOI: 10.1097/qai.0b013e3181b9e5ee.Peer-Reviewed Original ResearchConceptsCombined Hormonal ContraceptionGreater HOMA-IRNon-HC usersHormonal contraceptionHOMA-IRLow HDLHIV infectionMetabolic outcomesDensity lipoproteinWomen's Interagency HIV StudyHomeostasis model assessment estimateDisorders of glucoseAdverse metabolic outcomesHigh-density lipoproteinLow-density lipoproteinUninfected womenAntiretroviral therapyHigher HDLAdverse outcomesInsulin resistanceContraceptive efficacyHIV StudyReproductive ageCardiovascular diseaseHIV
2003
Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women.
Durante AJ, Williams AB, Da Costa M, Darragh TM, Khoshnood K, Palefsky JM. Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women. Cancer Epidemiology Biomarkers & Prevention 2003, 12: 638-42. PMID: 12869403.Peer-Reviewed Original ResearchConceptsAnal cytological abnormalitiesCohort of HIVSquamous intraepithelial lesionsAnal cytologyCytological abnormalitiesIntraepithelial lesionsRisk factorsHigh riskHuman immunodeficiency virus-infected womenAnal human papillomavirus (HPV) infectionAnal squamous intraepithelial lesionsAbnormal anal cytologyAnal HPV infectionHIV-uninfected counterpartsNormal baseline cytologyT-cell countsHPV DNA testingHuman papillomavirus infectionPotential risk factorsBaseline cytologyHPV infectionPapillomavirus infectionCigarette smokersImmune suppressionHIV